Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux.

Pax3cre-mediated deletion of fibroblast growth factor receptor 2 (Fgfr2) broadly in renal and urinary tract mesenchyme led to ureteric bud (UB) induction defects and vesicoureteral reflux (VUR), although the mechanisms were unclear. Here, we investigated whether Fgfr2 acts specifically in peri-Wolff...

Full description

Bibliographic Details
Main Authors: Kenneth A Walker, Sunder Sims-Lucas, Valeria E Di Giovanni, Caitlin Schaefer, Whitney M Sunseri, Tatiana Novitskaya, Mark P de Caestecker, Feng Chen, Carlton M Bates
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3567073?pdf=render
_version_ 1818281990736052224
author Kenneth A Walker
Sunder Sims-Lucas
Valeria E Di Giovanni
Caitlin Schaefer
Whitney M Sunseri
Tatiana Novitskaya
Mark P de Caestecker
Feng Chen
Carlton M Bates
author_facet Kenneth A Walker
Sunder Sims-Lucas
Valeria E Di Giovanni
Caitlin Schaefer
Whitney M Sunseri
Tatiana Novitskaya
Mark P de Caestecker
Feng Chen
Carlton M Bates
author_sort Kenneth A Walker
collection DOAJ
description Pax3cre-mediated deletion of fibroblast growth factor receptor 2 (Fgfr2) broadly in renal and urinary tract mesenchyme led to ureteric bud (UB) induction defects and vesicoureteral reflux (VUR), although the mechanisms were unclear. Here, we investigated whether Fgfr2 acts specifically in peri-Wolffian duct stroma (ST) to regulate UB induction and development of VUR and the mechanisms of Fgfr2 activity.We conditionally deleted Fgfr2 in ST (Fgfr2(ST-/-)) using Tbx18cre mice. To look for ureteric bud induction defects in young embryos, we assessed length and apoptosis of common nephric ducts (CNDs). We performed 3D reconstructions and histological analyses of urinary tracts of embryos and postnatal mice and cystograms in postnatal mice to test for VUR. We performed in situ hybridization and real-time PCR in young embryos to determine mechanisms underlying UB induction defects.We confirmed that Fgfr2 is expressed in ST and that Fgfr2 was efficiently deleted in this tissue in Fgfr2(ST-/-) mice at embryonic day (E) 10.5. E11.5 Fgfr2(ST-/-) mice had randomized UB induction sites with approximately 1/3 arising too high and 1/3 too low from the Wolffian duct; however, apoptosis was unaltered in E12.5 mutant CNDs. While ureters were histologically normal, E15.5 Fgfr2(ST-/-) mice exhibit improper ureteral insertion sites into the bladder, consistent with the ureteric induction defects. While ureter and bladder histology appeared normal, postnatal day (P) 1 mutants had high rates of VUR versus controls (75% versus 3%, p = 0.001) and occasionally other defects including renal hypoplasia and duplex systems. P1 mutant mice also had improper ureteral bladder insertion sites and shortened intravesicular tunnel lengths that correlated with VUR. E10.5 Fgfr2(ST-/-) mice had decreases in Bmp4 mRNA in stromal tissues, suggesting a mechanism underlying the ureteric induction and VUR phenotypes.Mutations in FGFR2 could possibly cause VUR in humans.
first_indexed 2024-12-13T00:13:54Z
format Article
id doaj.art-27336f0a723a4a379b51629d31793d8e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T00:13:54Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-27336f0a723a4a379b51629d31793d8e2022-12-22T00:05:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5606210.1371/journal.pone.0056062Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux.Kenneth A WalkerSunder Sims-LucasValeria E Di GiovanniCaitlin SchaeferWhitney M SunseriTatiana NovitskayaMark P de CaesteckerFeng ChenCarlton M BatesPax3cre-mediated deletion of fibroblast growth factor receptor 2 (Fgfr2) broadly in renal and urinary tract mesenchyme led to ureteric bud (UB) induction defects and vesicoureteral reflux (VUR), although the mechanisms were unclear. Here, we investigated whether Fgfr2 acts specifically in peri-Wolffian duct stroma (ST) to regulate UB induction and development of VUR and the mechanisms of Fgfr2 activity.We conditionally deleted Fgfr2 in ST (Fgfr2(ST-/-)) using Tbx18cre mice. To look for ureteric bud induction defects in young embryos, we assessed length and apoptosis of common nephric ducts (CNDs). We performed 3D reconstructions and histological analyses of urinary tracts of embryos and postnatal mice and cystograms in postnatal mice to test for VUR. We performed in situ hybridization and real-time PCR in young embryos to determine mechanisms underlying UB induction defects.We confirmed that Fgfr2 is expressed in ST and that Fgfr2 was efficiently deleted in this tissue in Fgfr2(ST-/-) mice at embryonic day (E) 10.5. E11.5 Fgfr2(ST-/-) mice had randomized UB induction sites with approximately 1/3 arising too high and 1/3 too low from the Wolffian duct; however, apoptosis was unaltered in E12.5 mutant CNDs. While ureters were histologically normal, E15.5 Fgfr2(ST-/-) mice exhibit improper ureteral insertion sites into the bladder, consistent with the ureteric induction defects. While ureter and bladder histology appeared normal, postnatal day (P) 1 mutants had high rates of VUR versus controls (75% versus 3%, p = 0.001) and occasionally other defects including renal hypoplasia and duplex systems. P1 mutant mice also had improper ureteral bladder insertion sites and shortened intravesicular tunnel lengths that correlated with VUR. E10.5 Fgfr2(ST-/-) mice had decreases in Bmp4 mRNA in stromal tissues, suggesting a mechanism underlying the ureteric induction and VUR phenotypes.Mutations in FGFR2 could possibly cause VUR in humans.http://europepmc.org/articles/PMC3567073?pdf=render
spellingShingle Kenneth A Walker
Sunder Sims-Lucas
Valeria E Di Giovanni
Caitlin Schaefer
Whitney M Sunseri
Tatiana Novitskaya
Mark P de Caestecker
Feng Chen
Carlton M Bates
Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux.
PLoS ONE
title Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux.
title_full Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux.
title_fullStr Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux.
title_full_unstemmed Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux.
title_short Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux.
title_sort deletion of fibroblast growth factor receptor 2 from the peri wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux
url http://europepmc.org/articles/PMC3567073?pdf=render
work_keys_str_mv AT kennethawalker deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux
AT sundersimslucas deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux
AT valeriaedigiovanni deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux
AT caitlinschaefer deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux
AT whitneymsunseri deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux
AT tatiananovitskaya deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux
AT markpdecaestecker deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux
AT fengchen deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux
AT carltonmbates deletionoffibroblastgrowthfactorreceptor2fromtheperiwolffianductstromaleadstouretericinductionabnormalitiesandvesicoureteralreflux